How do I store HGH before and after reconstitution?

Somatropin is recombinant human growth hormone — a 191-amino-acid single-chain polypeptide produced in E. coli or mammalian expression systems. It is a structurally fragile protein with three well-characterised degradation pathways in aqueous solution: methionine oxidation at residue 14, asparagine deamidation at residues 149 and 152, and aggregation through disulfide scrambling and non-covalent dimerisation. Temperature is the primary kinetic driver; every 10 °C rise in storage temperature approximately doubles the rate of each degradation pathway.

Lyophilised somatropin (freeze-dried powder)

The dry cake is substantially more stable than reconstituted solution because the three degradation pathways require water mobility to proceed. Residual moisture in the lyophilised cake is <1% in well-manufactured preparations, which is below the threshold for meaningful degradation rate at refrigerator temperature.

Storage windows:

• 2–8 °C (standard refrigerator): 18–24 months from manufacture date. The lyophilised form is at its most stable here.
• 20–25 °C (room temperature): tolerable for up to 30 days total cumulative exposure (transit plus short-term storage). Activity loss ~5–10% at 30 days.
• 25–30 °C: measurable degradation accelerates. 1 week exposure at 30 °C loses ~10–20% activity.
• >30 °C: do not use if the vial has been exposed for extended periods. The degradation curve steepens non-linearly above 30 °C.
• <0 °C: do not freeze. Ice nucleation in residual moisture disrupts protein folding in the dry state — lyophilisation protects against freeze damage in the manufacturing step but does not confer freeze-stability for storage.

Cold-chain logistics during transit is the single most-controllable variable. Insulated mailer + cold pack shipping through warm months (May–September in EU latitudes) is standard of care for HGH. On receipt, move to refrigerator within 30 minutes of unboxing.

Reconstituted somatropin

Aqueous solution is the active-degradation environment. Shelf life drops from months to weeks depending on the diluent.

With bacteriostatic water (0.9% benzyl alcohol):

• 2–8 °C refrigerated: 14–21 days stable. Some manufacturer-specific formulations hold 28 days; generic lyophilised preparations typically track to the shorter end.
• Above 8 °C: do not store. Degradation rate at 25 °C is ~10× the refrigerator rate.

With sterile water (no preservative):

• 2–8 °C refrigerated: 48–72 hours maximum. Single-use reconstitution only.
• Multi-dose use with sterile water is not supported. Microbial contamination risk rises before peptide degradation becomes limiting.

Manufacturer-specific note: pharmacy-grade pens (Humatrope, Norditropin, Genotropin) use proprietary stabiliser formulations and achieve 28-day post-broach stability on package insert. Research-grade lyophilised vials reconstituted with standard bac water do not match this window — plan around the 14–21 day ceiling.

Reconstitution technique

1. Remove HGH vial and bac water from refrigerator. Rest 10 minutes at room temperature. Thermal shock during cold-water injection onto cold-vial increases aggregation risk.
2. Wipe both stoppers with 70% isopropyl alcohol. Dry 10 seconds before needle insertion.
3. Draw 1 mL bac water per 10 IU HGH as the standard concentration. Alternative ratios change dose-per-unit arithmetic without affecting stability meaningfully.
4. Inject bacteriostatic water slowly down the inside wall of the HGH vial — do not aim the stream at the lyophilised cake. Foam generation is the primary technique error and produces immediate surface denaturation.
5. Do not shake. Swirl gently for 10–15 seconds.
6. Rest 2–3 minutes undisturbed to complete dissolution.
7. Inspect the solution: clear, colourless, no visible particulate. Any cloudiness or floating material is discard criterion.

Dosing arithmetic

10 IU HGH + 1 mL bac water = 10 IU/mL concentration on a U-100 insulin syringe:

• Full 1 mL (100 units) = 10 IU
• 0.1 mL (10 units on syringe) = 1 IU
• Standard 2 IU dose = 0.2 mL = 20 units
• Standard 4 IU dose = 0.4 mL = 40 units

Alternate ratio for lower doses: 10 IU in 2 mL = 5 IU/mL, so 2 IU = 0.4 mL = 40 units. The arithmetic fits a 100-unit syringe scale more cleanly at low-dose protocols.

Travel logistics

HGH outside refrigeration enters the degradation-active regime. Quantitative estimates from manufacturer-reported data:

• 1–4 hours room temperature transit: negligible activity loss (<2%).
• 24 hours room temperature: 5–15% activity loss.
• 72 hours room temperature: 15–30% activity loss depending on exact temperature profile.
• Insulated bag with cold pack, typical duration: 24–48 hours safe transit, minimal loss.

Dedicated medication coolers (Frio wallet, TempArmour, insulated insulin cases) provide 24–48 hours of active cooling from a single charge and are the appropriate tool for regular travel with active HGH. These are 25–40 EUR purchases; the economic case relative to protocol disruption is straightforward.

Indicators of degraded HGH

• Reconstituted solution cloudy or showing particulate. Aggregation confirmed. Discard.
• Absence of expected clinical markers at usual dose. First-week HGH at 2+ IU daily typically produces peripheral paresthesias (tingling in fingers, carpal-tunnel-like pressure), water retention, and subjectively more vivid dreams. Consistent absence of these after 14 days at a reliable dose suggests product compromise.
• IGF-1 bloodwork flat after 6 weeks of daily dosing. The definitive bioactivity test. Fresh, properly-stored HGH at 2–4 IU daily raises IGF-1 by 30–80% above baseline within 4–6 weeks. No rise indicates either compromised product or significantly sub-therapeutic dose; IGF-1 is the only objective measure.

IGF-1 costs 20–35 EUR at private EU labs. Pulling it at week 6 of any new HGH vial validates the product, establishes baseline for dose titration, and catches compromised batches before weeks of expected effect are wasted on a degraded preparation.